Vivakor enters global licensing agreement with MIT Holding for Vivathermic Vials

Vivakor, Inc. (OTCBB:VIVK) announces today that it has entered into an exclusive licensing agreement with MIT Holding Inc. (OTCBB:MITD) to manage all distribution of its Vivathermic Vials worldwide. Chairman Matt Nicosia adds the following statement to the news: "This is a great step forward in the distribution of Vivakor technology. Our Vivathermic vials are the most sensitive vials on the market for biological transportation and storage.  Vivathermic vials are used in all aspects of biological preservation including the most sensitive stem cells.  We envision the demand for Vivathermic vials will continue to increase over the next five years as these vials could become the standard for all biological storage and transportation.  Vivakor searched for a distribution partner that shared its vision of extending the length and quality of life while also increasing the value of the technology and enhancing shareholder value. This distribution agreement with MIT Holding Inc. creates a distribution opportunity and a long term commercialization partner for Vivakor Technologies."

MIT Holding Inc.'s Co-Chairman and Co-President, Walter H.C. Drakeford, added the following statement, "MIT Holding Inc. continues forward with its objective and mission of improving the quality of life.  Vivathermic technology is a piece of that objective and adds to our portfolio of technologies as we continue to build shareholder value while improving life."

SOURCE Vivakor Inc.